LimH, DevesaSS, SosaJA, CheckD, KitaharaCM. 2017. Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA, 317:1338–1348.
2.
AhnHS, WelchHG. 2015. South Korea's thyroid-cancer “epidemic”—turning the tide. N Engl J Med, 373:2389–2390.
3.
PowersAE, MarcadisAR, LeeM, MorrisLG, MartiJL. 2019. Changes in trends in thyroid cancer incidence in the United States, 1992 to 2016. JAMA, 322:2440–2441.
4.
CooperDS, DohertyGM, HaugenBR, KloosRT, LeeSL, MandelSJ, MazzaferriEL, McIverB, PaciniF, SchlumbergerM, ShermanSI, StewardDL, TuttleRM. 2009. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19:1167–1214.
5.
HaugenBR, AlexanderEK, BibleKC, DohertyGM, MandelSJ, NikiforovYE, PaciniF, RandolphGW, SawkaAM, SchlumbergerM. 2016. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 26:1–133.
6.
EtzioniR, PensonDF, LeglerJM, Di TommasoD, BoerR, GannPH, FeuerEJ. 2002. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst, 94:981–990.
